𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose chemotherapy appears effective in urothelial carcinoma

Book ID
120871141
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2000
Weight
138 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High dose chemotherapy in ovarian carcin
High dose chemotherapy in ovarian carcinoma
✍ HΓ©ron, J.F.; L'HommΓ©, C.; Kerbrat, P.; Mayer, F.; Chevallier, B.; Goupil, A.; Ve πŸ“‚ Article πŸ“… 1993 πŸ› Elsevier Science 🌐 English βš– 136 KB
High dose chemotherapy for refractory ur
High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantation
✍ Masanori Nishimura; Kaori Nasu; Hitoya Ohta; Masayuki Shintaku; Youichi Takahash πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

## BACKGROUND. Chemotherapy with methotrexate (MTX), vinblastine, doxorubicin, and cisplatin (M-VAC) is reported to be the most effective regimen for urothelial carcinoma. Complete response (CR) is observed in many cases. However, to the authors' knowledge there is no alternative therapy for nonre

High dose chemotherapy : Rationale and r
High dose chemotherapy : Rationale and results in breast carcinoma
✍ Robert E. Coleman πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## BACKGROUND. High dose chemotherapy (HDC) with hematopoietic stem cell support is an increasingly important strategy in the management of advanced cancer. Early Phase II studies and the development of peripheral blood stem cell support to enable safe and tolerable myeloablative chemotherapy has